Table 1.
Vaccine uptake across the surveys according to age and gender.
| VARIABLES | SNHS 2011 | EHS 2014 | SNHS 2017 | EHS 2020 | TOTAL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | NO DM | p-Value | DM | NO DM | p-Value | DM | NO DM | p-Value | DM | NO DM | p-Value | DM | NO DM | p-Value | |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | ||||||
| Age Groups (Years) | |||||||||||||||
| 18–49 | 34 (20.2) |
9 (5.4) |
<0.001 | 42 (24.1) |
9 (5.2) |
<0.001 | 32 (20.8) |
8 (5.2) |
<0.001 | 35 (25.7) |
9 (6.6) |
<0.001 | 143 (22.6) |
35 (5.5) |
<0.001 |
| 50–64 | 188 (36.4) |
98 (19) |
<0.001 | 183 (37.9) |
90 (18.6) |
<0.001 | 197 (37.6) |
86 (16.4) |
<0.001 | 150 (29.5) |
69 (13.6) |
<0.001 | 718 (35.3) |
343 (16.9) |
<0.001 |
| 65–74 | 285 (60.9) |
227 (48.5) |
<0.001 | 322 (58.5) |
254 (46.2) |
<0.001 | 375 (55.9) |
281 (41.9) |
<0.001 | 363 (57.6) |
270 (42.9) |
<0.001 | 1345 (58.0) |
1032 (44.5) |
<0.001 |
| 75 or older | 425 (68.5) |
406 (65.5) |
0.251 | 469 (70.6) |
433 (65.2) |
0.034 | 526 (68.4) |
491 (64) |
0.069 | 519 (67.1) |
484 (62.5) |
0.066 | 1939 (68.6) |
1814 (64.2) |
<0.001 |
| Gender | |||||||||||||||
| Male | 505 (52) |
444 (45.7) |
0.006 | 538 (54.9) |
447 (45.6) |
<0.001 | 572 (53.3) |
461 (42.9) |
<0.001 | 568 (55) |
431 (41.8) |
<0.001 | 2183 (53.8) |
1783 (43.9) |
<0.001 |
| Female | 427 (53.2) |
296 (36.9) |
<0.001 | 478 (53.6) |
339 (38) |
<0.001 | 558 (53.4) |
405 (38.9) |
<0.001 | 499 (49.1) |
401 (39.4) |
<0.001 | 1962 (52.3) | 1441 (38.4) |
<0.001 |
| Total Per Survey | 932 (52.6) |
740 (41.7) |
<0.001 | 1016 (54.3) |
786 (42.0) |
<0.001 | 1130 (53.4) |
866 (40.9) |
<0.001 | 1067 (52.1) |
832 (40.6) |
<0.001 | 4145 (53.1) |
3224 (41.3) |
<0.001 |
DM: individuals with diabetes mellitus. NO DM: individuals without diabetes mellitus. SNHS 2011: Spanish National Health Survey 2011. EHS 2014: European Health Survey 2014. SNHS 2017: Spanish National Health Survey 2017. EHS 2020: European Health Survey 2020.